Vnitr Lek 2007, 53(7-8):804-806

Autoimmune polyglandular syndromes: clinical aspects

K. Vondra
Endokrinologický ústav Praha, ředitel doc. MUDr. Vojtěch Hainer, CSc.

The history of autoimmune polyglandular syndromes (APS) and the basic characteristics of types 1 and 2 are briefly introduced. The clinical aspects of the more common type 2 are discussed in more detail from the point of view of the endocrinological and diabetological practice. The diagnosis aspects of preclinical, subclinical and manifestation stage of the main diseases occurring along with APS are briefly mentioned as well as the treatments and their challenges cause by the combination of various endocrine and non-endocrine autoimmune diseases. It is emphasized that care for there patients is a life-long process and that the health condition of these patients is usually very complicated. In some cases the combination of various disease conditions can make these patients completely disabled.

Keywords: autoimmune polyglandular syndromes; diabetes mellitus type 1; autoimmune tyroiditis; Addison's disease

Received: May 14, 2007; Published: July 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vondra K. Autoimmune polyglandular syndromes: clinical aspects. Vnitr Lek. 2007;53(7-8):804-806.
Download citation

References

  1. Maclaren NK. Autoimmune polyglandular syndromes In: DeGroot LJ, Jameson JL (eds). Endocrinology. 5th Edition. Philadelphia (PA): Elsevier Saunders 2006: 819-836.
  2. Dvořáková K, Vondra K. Asociované imunoendokrinopatie a genetika. In: Stárka L. Pokroky v endokrinologii. Praha: Maxdorf 2007: 240-253.
  3. Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes. Immunogenetics and long-term follow-up. J Clin Endocrinol Metab 2003; 88: 2983-2992. Go to original source... Go to PubMed...
  4. Vondra K, Vrbíková J, Bendlová B et al. Differences in Type I diabetes mellitus of young adults with and without thyroid autoimmunity. Exp Clin Endocrinol Diabetes 2005; 113: 404-408. Go to original source... Go to PubMed...
  5. Vondra K, Vrbíková J, Sterzl I et al. Tyroidální autoimunita u dospělých diabetiků 1. typu. Vlastní zkušenosti z 11letého sledování. Vnitř Lék 2006; 52: 864-872. Go to PubMed...
  6. Kunishige M, Sekimoto E, Komatsu M et al. Thyrotoxicosis masked by diabetic ketoacidosis. Diabetes Care 2001; 24: 171. Go to original source... Go to PubMed...
  7. Vondra K, Zamrazil V. Endokrinní systém a diabetes mellitus. In: Blahoš J, Zamrazil V (eds). Endokrinologie. Interdisciplinární obor. Praha: Triton 2006: 353-366.
  8. Zamrazil V, Vondra K. Endokrinní onemocnění u diabetiků. In: Perušičová J. Trendy soudobé diabetologie. Praha: Galén 2004,Vol 9: 11-28.
  9. Vondra K, Hampl R. Glukokortikoidy a diabetes mellitus. Vnitř Lék 2006; 52: 493-497. Go to PubMed...
  10. Mohn A, Di Michele S, Di Luzio R et al. The effect of subclinical hypothyroidism on metabolic control in children and adolescents with Type 1 diabetes mellitus. Diabet Med 2002; 19: 70-73. Go to original source... Go to PubMed...
  11. Giordano R, Pellegrino M, Oleandri S et al. Adrenal sensitivity to adrenocorticotropin 1-24 is reduced in patients with autoimmune polyglandular syndrome. J Clin Metab 2004; 89: 675-680. Go to original source... Go to PubMed...
  12. Kalmann R, Mourits MP. Diabetes mellitus: a risk factor in patients with Graves' orbitopathy. Br J Ophthalmol 1999; 83: 463-465. Go to original source... Go to PubMed...
  13. Salátová M, Vondra K. Autoimunitní polyglandulární syndrom 2. typu v ordinaci praktického lékaře. Prakt Lék 2007; 87: 169-172.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.